Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04584541Terminated
Trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Detection of SARS-CoV-2 RNA in feces and nasopharyngeal swabs at Day 90, Detection and quantification of IgG, IgM and IgA specific for SARS-CoV-2 N and S proteins in blood at 24 months and 1 more. Started Jun 2020; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04584541.